Market Makers top 20; Immersion Corp assertions; InterDigital v Lenovo FRAND decision; SVB collapse; pharma patent debate; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.

MONDAY 13 March

Help us to choose this year’s IP Hall of Fame inductees. Nominate here

US-based NPE Immersion Corporation has embarked on its latest patent assertion, suing Xiaomi in France, Germany and India. Read more here

Data dive: Uncovering US trade secret case trends. Read more here

TUESDAY 14 March

DEI: Neurodiversity and mental health – Celebrating difference in the IP profession. Read more here

Five patent takeaways from Pfizer’s $43 billion Seagen buyout. Read more here

Senate IP subcommittee appointments inspire cautious optimism for patent owners. Read more here


The Market Makers of 2022: top 20 revealed. Read more here

Key things to watch in US Supreme Court oral argument in Amgen v Sanofi. Read more here


Weekly column: SVB’s collapse is a reminder of how far IP finance still has to travel. Read more here

InterDigital v Lenovo FRAND decision handed down after long wait. Read more here

EDTX judge’s new limine order takes name-calling off the table. Read more here

FRIDAY 17 March

DEI: Women leaving legal profession in Malaysia despite lack of 'glass ceiling'. Read more here

Moderna’s efforts to deflect covid vaccine infringement liability run into more difficulties. Read more here

Federal Circuit protects infringement demand letters as free speech. Read more here


Opinion: We need a better debate about US pharma patents. Read more here

Unlock unlimited access to all IAM content